October 17, 2011
STELLAPHARM was born to care and protect patient’s health, to help enhancing their lives and living longer. Your health, for today and for future.
Possession of a harmonious body and good health is the wish of many people, especially women. However, the big concern and worry of most of women is how to choose the most effective and safe method
Following the Advertising Campaign for the Orlistat STADA Diet Pill from April 2010, on July 7, August 13, August 20 and 9 September 2011, STADA-VN JOINT VENTURE CO., LTD co-operated with Exclusive Distributor – Khuong Duy Pharmaceutical Co., Ltd to organize the Customer Meeting in Hochiminh City, Vung Tau City and Ban Me Thuot City with the topic of “Safe and Economic Diet with Orlistat STADA“. In the meeting, besides the feedback on how to choose a safe diet pill without any active elements which may cause harmful effect to health, Consultants of STADA-VN JOINT VENTURE CO., LTD also held discussion to explain the efficiency of the productsas well as consulted various diet assistance methods which can bring the best effect.
Participants were doctors, pharmacists who were working for hospitals, pharmacies in Hochiminh City and other concer provinces.
The Conference will also be held at Bien Hoa city on 15 October 2011.
STELLAPHARM is one of leading generics pharmaceutical companies and strong producer of anti-viral drugs in Vietnam. The company established in Vietnam in 2000; and focuses on both prescription drugs and non-prescription especially in cardiovascular diseases, anti-viral drugs, anti-diabetics drugs, etc. and our products are now used by millions of patients in more than 50 countries worldwide.
The company is globally recognized for its quality through our facilities have been audited and approved by stringent authority like EMA, PMDA, Taiwan GMP, local WHO and others.
Additional information for this article: Stellapharm J.V. Co., Ltd. – Branch 1
A: 40 Tu Do Avenue, Vietnam – Singapore Industrial Park, An Phu Ward, Thuan An Town, Binh Duong Province, Vietnam
T: +84 274 376 7470 | F: +84 274 376 7469 | E: email@example.com | W: www.stellapharm.com
Sept 29 (Reuters) – Laboratory studies show that Merck & Co’s (MRK.N) experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective against known variants of the coronavirus, including the dominant, highly transmissible Delta, the company said on Wednesday. Since molnupiravir does not target the spike protein of the virus – the target of
Since the beginning of February this year, many consignments of Stella’s pharmaceutical products with a total of nearly 200 million units have been urgently exported by air to markets in Germany, France, Austria, Belgium, Ireland, etc.